Skip to main content
R1 RCM Inc. (RCM)
NASDAQ: RCM · IEX Real-Time Price · USD
10.90
-1.66 (-13.22%)
At close: Jul 2, 2024, 4:00 PM
11.11
+0.21 (1.93%)
After-hours: Jul 2, 2024, 7:55 PM EDT

R1 RCM Revenue

R1 RCM had revenue of $2.31B in the twelve months ending March 31, 2024, with 17.61% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $603.90M with 10.69% year-over-year growth. In the year 2023, R1 RCM had annual revenue of $2.25B with 24.79% growth.

Revenue (ttm)
$2.31B
Revenue Growth
+17.61%
P/S Ratio
1.99
Revenue / Employee
$77,083
Employees
30,000
Market Cap
4.59B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20232.25B447.80M24.79%
Dec 31, 20221.81B331.80M22.50%
Dec 31, 20211.47B204.50M16.10%
Dec 31, 20201.27B84.00M7.08%
Dec 31, 20191.19B317.60M36.57%
Dec 31, 2018868.50M418.70M93.09%
Dec 31, 2017449.80M-142.80M-24.10%
Dec 31, 2016592.60M475.40M405.63%
Dec 31, 2015117.20M-92.94M-44.23%
Dec 31, 2014210.14M-294.63M-58.37%
Dec 31, 2013504.77M432.51M598.60%
Dec 31, 201272.25M-29.71M-29.14%
Dec 31, 2011101.97M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Select Medical Holdings 6.79B
Option Care Health 4.43B
PACS Group 3.34B
RadNet 1.66B
Haemonetics 1.31B
Apellis Pharmaceuticals 524.07M
TransMedics Group 296.92M
CRISPR Therapeutics AG 271.71M
Revenue Rankings

RCM News

More News